Skip to content

Effect of essential oil of lavender on duration of pregnancy in primigravida women with late preterm labor

Effect of essential oil of lavender on duration of pregnancy in primigravida women with late preterm labor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015051422280N1
Enrollment
60
Registered
2015-09-15
Start date
2015-04-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pereterm labor. Onset (spontaneous) of labour before 37 completed weeks of gestation

Interventions

Intervention 1: Control 1: sweet almond oil place the abdominal locally to 3 drops 3 times a day. Intervention 2: Intervention group: lavender essential oil diluted 1: 9 in Place of intervention: abdo
Placebo
Treatment - Drugs
Control 1: sweet almond oil place the abdominal locally to 3 drops 3 times a day
Intervention group: lavender essential oil diluted 1: 9 in Place of intervention: abdominal locally to 3 drops 3 times a day
Control 2: without intervention

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: first pregnancy; living in Mashhad city, Iran; gestational age based on the first day of the last menstrual period or by Sonography be 34 – 36.6 weeks; diagnosis of late preterm labor; the desire to participate in the study have; age between 18 to 35 years old; no specific disease; normal amniotic sac; no fever ( Temperature =38° C); have Iranian nationality; have literacy; singleton pregnancy; no fetal distress; no contraindications for aromatherapy such as asthma; during the last 6 months have been a horrible accident; no embryonic and fetal anomalies by ultrasound during pregnancy. Exclusion criteria: allergic to lavender essential oil; accidents happen during research; unwillingness to continue taking the drug by patients; complications such as severe disability, or at least a continuous weeks or more than 3 days of medication per week; have fever(oral temp =38 ° C).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Length of pregnancy. Timepoint: After intervention until delivery. Method of measurement: Medical records.

Secondary

MeasureTime frame
Anxiety. Timepoint: Before the intervention, and every day after intervention. Method of measurement: Visual analgous Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Bolghanabadi

School of Nursing and Midwifery, Mashhad University of Medical Sciences

bolghanabadiz911@mums.ac.ir; bolghanabadiz67@gmail.com+98 51 3859 1511

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026